본문 바로가기
KERD
논문KCI 등재

Hepatocellular carcinoma incidence is decreasing in Korea but increasing in the very elderly

정승원|Jonghyun Lee|전대원|Eileen Yoon|Sang Bong Ahn|Soon Sun Kim|Young Eun Chon|Seong Yong Park|Han Pyo Hong|Donghee Son
대한간학회 (The korean Association for the Study of the Liver)|2023.02|Clinical and Molecular Hepatology|제29권 제1호|pp. 120-134

2

조회

0

다운로드

7

인용

0

참고문헌

키워드

KoreaIncidencePredictionHepatocellular carcinomaAge-standardized incidence rate

초록

Background/Aims: A comprehensive analysis of trends in the incidence of hepatocellular carcinoma (HCC) is important for planning public health initiatives. We aimed to analyze the trends in HCC incidence in South Korea over 10 years and to predict the incidence for the year 2028. Methods: Data from patients with newly diagnosed HCC between 2008 and 2018 were obtained from Korean National Health Insurance Service database. Age-standardized incidence rates (ASRs) were calculated to compare HCC incidence. A poisson regression model was used to predict the future incidence of HCC. Results: The average crude incidence rate (CR) was 22.4 per 100,000 person-years, and the average ASR was 17.6 per 100,000 person-years between 2008 and 2018. The CR (from 23.9 to 21.2 per 100,000 person-years) and ASR (from 21.9 to 14.3 per 100,000 person-years) of HCC incidence decreased during the past ten years in all age groups, except in the elderly. The ASR of patients aged ≥80 years increased significantly (from 70.0 to 160.2/100,000 person-years; average annual percent change, +9.00%; P<0.001). The estimated CR (17.9 per 100,000 person-years) and ASR (9.7 per 100,000 person-years) of HCC incidence in 2028 was declined, but the number of HCC patients aged ≥80 years in 2028 will be quadruple greater than the number of HCC patients in 2008 (from 521 to 2,055), comprising 21.3% of all HCC patients in 2028. Conclusions: The ASRs of HCC in Korea have gradually declined over the past 10 years, but the number, CR, and ASR are increasing in patients aged ≥80 years.

Abstract

Background/Aims: A comprehensive analysis of trends in the incidence of hepatocellular carcinoma (HCC) is important for planning public health initiatives. We aimed to analyze the trends in HCC incidence in South Korea over 10 years and to predict the incidence for the year 2028. Methods: Data from patients with newly diagnosed HCC between 2008 and 2018 were obtained from Korean National Health Insurance Service database. Age-standardized incidence rates (ASRs) were calculated to compare HCC incidence. A poisson regression model was used to predict the future incidence of HCC. Results: The average crude incidence rate (CR) was 22.4 per 100,000 person-years, and the average ASR was 17.6 per 100,000 person-years between 2008 and 2018. The CR (from 23.9 to 21.2 per 100,000 person-years) and ASR (from 21.9 to 14.3 per 100,000 person-years) of HCC incidence decreased during the past ten years in all age groups, except in the elderly. The ASR of patients aged ≥80 years increased significantly (from 70.0 to 160.2/100,000 person-years; average annual percent change, +9.00%; P<0.001). The estimated CR (17.9 per 100,000 person-years) and ASR (9.7 per 100,000 person-years) of HCC incidence in 2028 was declined, but the number of HCC patients aged ≥80 years in 2028 will be quadruple greater than the number of HCC patients in 2008 (from 521 to 2,055), comprising 21.3% of all HCC patients in 2028. Conclusions: The ASRs of HCC in Korea have gradually declined over the past 10 years, but the number, CR, and ASR are increasing in patients aged ≥80 years.

참고문헌 (26)

  1. Sung H, "Global cancer statistics 2020 : GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185countries", CA Cancer J Clin, 71, pp.209~249 (2021)
  2. Rawla P, "Update in global trends and aetiology of hepatocellular carcinoma", Contemp Oncol(Pozn), 22, pp.141~150 (2018)
  3. Korean Liver Cancer Association (KLCA) and National Cancer Center (NCC, "2018 Korean Liver Cancer Association–National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma", Gut and Liver, 13(3), pp.227~299 (2019), 거트앤리버 소화기연관학회협의회[DOI]
  4. 김보현, "Epidemiology of liver cancer in South Korea", Clinical and Molecular Hepatology, 24(1), pp.1~9 (2018), 대한간학회
  5. Dasgupta P, "Global trends in incidence rates of primary adult liver cancers : a systematic review and meta-analysis", Front Oncol, 10, pp.171~ (2020)
  6. Liu Z, "The trends in incidence of primary liver cancer caused by specific etiologies : results from the global burden of disease study 2016 and implications for liver cancer prevention", J Hepatol, 70, pp.674~683 (2019)
  7. Kim BK, "Changes in real-life practice for hepatocellular carcinoma patients in the Republic of Korea over a 12-year period : a nationwide random sample study", PLoS One, 14, pp.e0223678~ (2019)
  8. 전영은, "Hepatocellular Carcinoma in Korea between 2012 and 2014: an Analysis of Data from the Korean Nationwide Cancer Registry", Journal of Liver Cancer, 20(2), pp.135~147 (2020), 대한간암학회[DOI]
  9. Lee EY, "Trends of liver cancer and its major risk factors in Korea", Epidemiol Health, 37, pp.e2015016~ (2015)
  10. Jun Sik Yoon, "Hepatocellular Carcinoma in Korea Between 2008 and 2011: an Analysis of Korean Nationwide Cancer Registry", Journal of Liver Cancer, 20(1), pp.41~52 (2020), 대한간암학회[DOI]
  11. Kim BH, "Temporal improvement in survival of patients with hepatocellular carcinoma in a hepatitis B virus-endemic population", J Gastroenterol Hepatol, 33, pp.475~483 (2018)
  12. Cho EJ, "Current status and strategies for hepatitis B control in Korea", Clin Mol Hepatol, 23, pp.205~211 (2017)
  13. Cho EJ, "Relative etiological role of prior hepatitis B virus infection and nonalcoholic fatty liver disease in the development of non-B non-C hepatocellular carcinoma in a hepatitis B-endemic area", Digestion, 84(Suppl 1), pp.17~22 (2011)
  14. "2021hepatocellular carcinoma factsheet in Korea"[URL]
  15. Kwon S, "Health Systems in Transition. Vol 5" (2015), WHO Regional Office for the Western Pacific
  16. Korean Liver Cancer Study Group, "2014 Korean Liver Cancer Study Group-National Cancer Center Korea Practice Guideline for the Management of Hepatocellular Carcinoma", Korean Journal of Radiology, 16(3), pp.465~522 (2015), 대한영상의학회[DOI]
  17. Petrick JL, "Future of hepatocellular carcinoma incidence in the United States forecast through 2030", J Clin Oncol, 34, pp.1787~1794 (2016)
  18. Shiels MS, "Recent decline in hepatocellular carcinoma rates in the United States", Gastroenterology, 158, pp.1503~1505 (2020)
  19. Lee BS, "Nationwide seroepidemiology of hepatitis B virus infection in South Korea in 2009 emphasizes the coexistence of HBsAg and anti-HBs", J Med Virol, 85, pp.1327~1333 (2013)
  20. Jae-Jun Shim, "Predictive Value of Antiviral Effects in the Development of Hepatocellular Carcinoma in the General Korean Population with Chronic Hepatitis B", Gut and Liver, 10(6), pp.962~968 (2016), 거트앤리버 소화기연관학회협의회
  21. Anyiwe K, "Effect of socioeconomic status on hepatocellular carcinoma incidence and stage at diagnosis, a population-based cohort study", Liver Int, 36, pp.902~910 (2016)
  22. Cox AL, "Progress towards elimination goals for viral hepatitis", Nat Rev Gastroenterol Hepatol, 17, pp.533~542 (2020)
  23. Huang DQ, "Global epidemiology of NAFLD-related HCC : trends, predictions, risk factors and prevention", Nat Rev Gastroenterol Hepatol, 18, pp.223~238 (2021)
  24. Estes C, "Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030", J Hepatol, 69, pp.896~904 (2018)
  25. Hung GY, "Changing incidence patterns of hepatocellular carcinoma among age groups in Taiwan", J Hepatol, 63, pp.1390~1396 (2015)
  26. "Korean Statistical Information Service"[URL]

관련 논문AI추천

The emerging age-pattern changes of patients with hepatocellular carcinoma in KoreaBo Hyun Kim, Joong-Won Park, Yuri Cho대한간학회 · Clinical and Molecular Hepatology2023 · 제29권 제1호Epidemiology of liver cancer in South Korea김보현, Joong-Won Park대한간학회 · Clinical and Molecular Hepatology2018 · 제24권 제1호15-Year Trends in Hepatocellular Carcinoma: Epidemiology, Treatment, and Outcomes from a Hospital-Based RegistryChoi Jonggi, Choi Won-Mook, Kim Kang Mo, Kim Ki-Hun, Kim Songgyung, Lee Danbi, Lee Han Chu, Lim Young-Suk, Park Jina, Shim Ju Hyun거트앤리버 소화기연관학회협의회 · Gut and Liver2025 · 제19권 제5호Effectiveness of Hepatocellular Carcinoma Surveillance and an Optimal Surveillance Interval: Nationwide Cohort of Korea박미숙, 박수미, 배희진, 이상아, 최종원, 황신혜연세대학교의과대학 · Yonsei Medical Journal2021 · 제62권 제8호Surveillance Rate and its Impact on Survival of Hepatocellular Carcinoma Patients in South Korea: A Cohort Study김범희, 김진욱, 이정섭, 이주현, 임상혁, 장은선, 정숙향, 정정화대한암학회 · Cancer Research and Treatment2019 · 제51권 제4호Impact of nationwide hepatocellular carcinoma surveillance on the prognosis in patients with chronic liver diseaseDanbee Kang, Eliseo Guallar, Juhee Cho, Minwoong Kang, Won Sohn, Yong-Han Paik대한간학회 · Clinical and Molecular Hepatology2022 · 제28권 제4호

이 간행물의 다른 논문 (46건)

Subclinical versus advanced forms of alcohol-related liver disease: Need for early detectionLuma Melo, David Martí-Aguado, Ramón Bataller, Concepción Gómez-Medinapp. 1-15PrefaceYoon Jun Kimpp. 2-2PrefaceSeung Up Kimpp. 3-3Non-alcoholic fatty liver disease: Definition and subtypesSeul Ki Han, 김문영, 백순구pp. 5-16Management of refractory ascitesFlorence Wongpp. 16-32
원문 보기